logo
Hepatitis A incidence in the EU: what can we learn from the available data?
Prevalence of hepatitis B, hepatitis C and hepatitis D virus infections in Cameroon: results from a national population based survey (The ANRS 12289 project)
Virus-specific dimeric IgA: a new biomarker for acute viral hepatitis infections?
Molecular characterization of hepatitis D virus-associated hepatocellular carcinoma
Sorafenib interferes with signaling events important for NTCP-mediated HBV/HDV uptake
Naturally occurring novel mutation in C-terminal region of Hepatitis B virus X protein promotes proliferation of hepatoma cells through up-regulating miR-221 targeting cyclin-dependent kinase inhibitor (CDKI)
A recombinant expression system for differentially phosphorylated hepatitis B virus capsids
The impact of 25 years of sero-behavioural surveillance of blood borne viral infections among people who inject drugs in the United Kingdom
REP 2139 monotherapy and combination therapy with pegylated interferon: safety and potent reduction of HBsAg and HDV RNA in Caucasian Patients with chronic HBV/HDV co-infection
Hepatitis C virus stimulates murine CD8a-like dendritic cells to produce type I interferon in a TRIF-dependent manner
Dual function of RIG-I RNA helicase as an innate sensor and as a direct antiviral effector during hepatitis B virus infection
Study of the super-infection by Hepatitis B Virus (HBV) and Hepatitis Delta Virus (HDV) in the HepaRG cell model
Bispecific antibody constructs mediate specific retargeting towards and elimination of HBV-positive hepatocytes and tumor cells
Transcriptome analysis of host responses against HEV pORF3
Hepatitis E Seroprevalence in Europe: an assessment of serosurveys anti-HEV IgG seroprevalence in Europe: a meta-analysis
Hepatitis C virus infection downregulates lysophosphatidylcholine acyltransferase 1: a mechanism linking hepatic steatosis and production of lipo-viro-particles
mTORC1 is a novel HCV host factor
Towards a bivalent prophylactic vaccine against hepatitis B and C viruses?
Indeterminate acute liver failure: it may be Hepatitis E
Novel perspectives for Hepatitis A Virus therapy resulting from comparative analysis of Hepatitis C Virus and Hepatitis A Virus RNA replication
Human liver chimeric mice as a novel model for the study of hepatitis E virus infections
Outcome of patients with hepatocellular carcinoma treated with transarterial chemoembolisation
The German multicenter cohort on direct antiviral agents in HCV- and HIV/HCV-infected patients (GECODAA)
Ledipasvir/Sofosbuvir single tablet regimen is highly effective treatment for patients with HCV genotype 2 infection
Natural history and response to treatment of hepatitis C genotype-1b infection from a health-care associated, single source outbreak
Early HCV RNA kinetics predict relapse to sofosbuvir/ribavirin dual therapy
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of hepatitis c infection: interim analysis of a prospective, observational study
A randomized comparative open label trial of tenofovir monotherapy versus tenofovir plus telbuvidine dual therapy in spontaneous reactivation of hepatitis B (NCT01732224)
The efficacy of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis
Studies of nosocomial outbreaks of hepatitis B in nursing homes in Germany and the major role of hepatitis B e antigen expression in disease severity and progression
Acut Hepatitis A Infection in Istanbul
Bilirubin modulates the Hepatitis A virus-dependant T cell regulatory function through both, TIM-1 expression and TCR signaling pathway
Universal single-dose vaccination against hepatitis A in children in region with intermediate endemicity
The distribution and dynamic changes of serum 25(OH)D3 in Chinese chronic hepatitis B patients with nucleoside analogue treatment: results from a real-life setting study
Assessment of knowledge and practice towards Hepatitis B among medical and health science students in Haramaya University
Hepatitis B virus co-infection and its predisposing factors among HIV positives in fafaan zone of Ethiopian somali regional state: a comparative study between Pre-ART and ART Initiated
Sero-epidemiology of Hepatitis B among pregnant women attending antenatal clinic in selected health facilities in East Wollega Zone, Ethiopia
Development and validation of an Iranian version of the Burden of Viral Hepatitis Questionnaire
Hepatitis B in rural settlement projects in Central Brazil: Epidemiology and Vaccination
The global prevalence of chronic HBV infection: a systematic review and meta-analyses on 48 years of published data
HBV infection at the Sentinel Units network in Argentina, 2007-2014
Prevalence of Hepatitis B and Hepatitis C in patients with atherosclerosis in a tertiary care hospital
Association of Hepatitis and Syphilis
Longitudinal study of the mortality rates of patients with chronic Hepatitis B infection in a developed Asian community
Co-infection viruses Hepatitis B and delta: A picture of the western amazon
Molecular an seroepidemiologic aspects of hepatitis B and C infections in patients coinfected with human immunodeficiency viris in Campo Grande, Mato Grosso do Sul, Brazil
Prevalence of serological markers of hepatitis B virus infection among six ethnic groups living in Amsterdam, The Netherlands
Prevalence of markers of hepatitis-B in voluntary blood donors in Fatehabad district of Haryana
Signatures of T-bet and Eomes expression on virus-specific T-cells in hepatitis B virus infection
Combining Hepatitis B surface antigen (HBsAg) with Anthrax (rPA) for a single oral vaccine
The hepatitis B virus (HBV) surface antigen (HBsAg) prevents hepadnaviral replicationdependent interferon responses, which are mediated by non-parenchymal liver cells in a HBV transgenic mouse model
Studies on the mechanism of hepatitis B virus cccDNA inhibition by adenovirus early proteins
Prevalence and molecular characterization of Hepatitis B virus in blood donors in Botswana
CRISPR/Cas9 nickase-mediated inactivation of hepatitis B virus replication
Establishment of an Enzyme Linked Immunosorbent Assay (ELISA) for selective DHBeAg detection as surrogate marker for cccDNA formation
Association between the viral basal core promoter and precore mutations with the different clinical stages of patients with chronic Hepatitis B virus infection
Comparative microarray analysis of susceptible hepatoma cell lines upon infection with Hepatitis B (HBV) and Hepatitis delta virus (HDV)
Identification of specific heparan sulfate proteoglycans involved in the attachment of Hepatitis B and D viruses
Genotype D of hepatitis B virus and its subgenotypes in Brazil
Visualization of Myrcludex B-derived peptide binding to the hepatitis B virus receptor sodium taurocholate cotransporting polypeptide in mouse liver sections
Development and characterization of surface modified chitosan nanoparticles for selective targeting of lamivudine to hepatocyte
Development of bipolymer based novel nanoparticles in microsphere system as vaccine adjuvant
Antibody coated liposomes for transmucosal vaccination
An update on hepatitis B virus genotypes circulating in two Brazilian regions
Lipid based Nanoparticulate system for effective vaccine delivery
Role of translation initiation in productive HBV P protein-epsilon interaction
NonInvasive topical immunization using cholera toxin as adjuvant for the treatment of Hepatitis B
Interleukin-10 gene promoter polymorphisms and the outcome of Hepatitis B Virus infection
Association between Interleukin-12 receptor B1 gene polymorphism (rs401502 C/G) and chronic Hepatitis B Virus infection
Liquid Crystalline Nanoparticles (LCNPS) based delivery of an Anticancer bioactive, Methotrexate
Hepatitis B surface proteins (SHBs, LHBs and MHBs) decline after stopping of nucleos(t)ide analogue therapy in HBeAg-negative patients
Injecting drug users (IDUs) are prone to Hepatitis B because of the high risk behaviour. Hepatitis B can be prevented through vaccines but the IDUs and their sexual partners from Kathmandu, Nepal are not getting preventive hepatitis B vaccinations
Hepatitis B vaccination among crack users in Goiania City, Central Brazil
A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patients
Current trends and perspectives of Hepatitis B elimination program in the North-Western region of the Russian Federation
Viral Hepatitis B & C epidemiology, disease burden, prevention and control measures in Taraba state
Kinetics of humoral and cellular immune responses to hepatitis B revaccination 10-15 years after primary immunization in infancy
Micro RNAs miR-106a, miR-122 and mir-197 are increased in severe acute viral hepatitis with coagulopathy
Novel broadly-reactive neutralizing antibodies against hepatitis B virus surface antigen
HBV genotype fluctuation (shifting and reversion) after liver transplantation
Combination of artificial liver support system and nucleoside analogue treatment improves long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: A single-center experience
The response rates of current chronic viral Hepatitis B treatments
Hepatoprotective and anti-viral efficacy of Acacia mellifera leaves ethanolic-fractions against hepatitis B virus (HBV)
Hepatitis B - Which are the viral targets?
Efficacy and safety of Peginterferon alfa-2b (40 kD, Y Shape) (Pegberon) in HBeAg- positive CHB patients — a phase III, randomized, multicenter, positive-controlled, open-label clinical study
Entecavir is associated with decrease in libido in male patients with Hepatitis B: Report of two cases
Anti-HBV immunity induced by novel primeboost vaccination break tolerance and accelerated HBV clearance in HBV persistent infection mouse model
Incidence of hepatocellular carcinoma in chronic hepatitis B patients responders to nucleoside analogue treatment
Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?
A randomized comparative open label trial of tenofovir monotherapy versus tenofovir plus telbuvidine dual therapy in spontaneous reactivation of hepatitis B (NCT01732224)
Genome-wide analysis of mRNA and miRNA expression of hepatitis B virus (HBV)-associated acute liver failure reveals a dominant B-cell disease signature
Hepatitis B surface Antigen (HBsAg) levels in chronic hepatitis B patients - a comparison between patients of different ages and their hepatitisBeAntigen (HBeAg) seroconversion status in a prospective cohort
Hepatitis B Burden in a growing world: assessing the impact of demography and the effect of vaccination on future generations
Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes among chronically infected patients in Egypt
A cross sectional study of HBeAg negative chronic hepatitis B virus infection in Cape Town, South Africa
Discovery of novel inhibitors of the HBV infection in vitro
Risk factors associated with type 2 diabetes mellitus in patients with chronic hepatitis B: a cross-sectional study with pair-matched controls
Cytokine patterns of patients with HCV/HBV co-infection
Viral hepatitis A, B and C in an Afro-Brazilian community ten years after the first epidemiological and molecular survey
Serological profile and genotyping of hepatitis B virus in an isolated Afro-Brazilian community in Rio de Janeiro
Hepatitis B virus spliced variants are associated with failure to respond to interferon therapy
HBsAg Seroconversion and HBsAg persistence controlled by IL-17 producing CD8 T cells and T follicular Helper Cells (TFH)
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Hepatitis C virus seroprevalence in Russian Federation: results of population based study
Are diabetics less likely to have a cleared hepatitis C virus infection?
Hepatitis B and C among people who inject drugs in Germany: High HCV prevalence, low HBV immunization rates, and urgent need for prevention
Characterizing hepatitis C virus transmission dynamics using molecular phylogenetic-based methods
Birth cohort and risk factors in Hepatitis C patients recorded at the Sentinel Units Network in Argentina 2007-2014
Distribution of hepatitis C virus genotypes in Republic of Srpska
Hepatitis C genotypes in Bağcilar region
Prevalence of HIV, hepatitis B and C infection and an assessment of HCV-genotypes and two IL28B SNPs among people who inject drugs in three regions of Nepal
HCV genotypes distribution at the sentinel units network in Argentina
Quacks are quick regarding management of viral infections (HBV, HCV) mainly in rural (desert) areas of Pakistan
Limited utility of commonly used, serum-based fibrosis scores to predict histologic fibrosis stage in patients with chronic hepatitis C infection
Scaling up access to HCV treatment in Ukraine
Estimating the direct cost and survival benefit of chronic hepatitis C treatment in novel antiviral agent era, Thailand
Hepatitis C virus prevalence in the Horn of Africa sub-region of the Middle East and North Africa: systematic review and meta-analysis
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa
Seroprevalence of anti-HCV antibodies among voluntary blood donors in Fatehabad district of Haryana
Naturally occuring cross - resistance mutation to boceprevir and telaprevir in a naive chronic hepatitis-C patient: Presentation of a case
High-resolution determination of human hepatic immune cell signatures from fineneedle liver aspirates
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication via blockage of membranous web formation
HCV replication activity is modified by mTorinhibitors in vitro which is mediated by PML
Flunarizine, a clinically licensed diphenylmethylpiperazine and T-type calcium channel inhibitor prevents Hepatitis C virus membrane fusion in a genotype-dependent manner
More needles in the haystack - Hepatitis C virus can utilize various apolipoproteins to produce infectious progeny
Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of proviral host genes in hepatitis C virus infectio
Antiviral activity of human Kupffer cells, liver sinusoidal endothelial cells and hepatic stellate cells against Hepatitis C virus is restricted to toll-like receptor 3 stimulation and involves type I interferons
Effect of endogenous ligands of the high densitiy lipoprotein-receptor scavenger receptor class B type I on the replication cycle of the hepatitis C virus
Serum biomarker profile can predict the outcome of acute HCV infection
Intestinal microbiota in chronic hepatitis C: Differences in microbial communities in patients with and without liver cirrhosis
Structural and physicochemical studies of the fusion mechanisms and assembly of Hepatitis C Virus
Emergence of a HCV genotype genomic variant with elements of type 1 and 2 in Georgia
Impact of genetic polymorphisms in the SCARB1 gene on hepatitis C virus
Analysis of RASSF1A and DOK1 promoters methylation levels in hepatic tissues with and without hepatocellular carcinoma by pyrosequencing
GSTM1 , GSTT1 , MDM2 and p53 polymorphisms and hepatitis C virus genetic variability in Brazilian patients with and without hepatocellular carcinoma
Viral adaptation approaches to adapt hepatitis C virus to the murine host
Hepatitis C virus NS3 polymorphism Q80K in genotype 1 therapy-naive Brazilian patients
Influence of liver normoxia on intra- and extra-hepatic NK cell function in HCV infection
Immunoglobulin purified from antibody associated virus from hepatitis C viraemic sera exhibit selective targeting of homologous HCV genotype
Human pDC potentially carrying two alleles with reconstituted IFN-λ4 gene function show reduced IFN-α induction upon stimulation with HCV infected hepatoma cells
The Impact of obesity-related hormones on the HCV life-cycle
Hepatitis C Virus mediates NRG1-dependent down-regulation of ErbB3, thereby modifies ErbB receptor family composition at the cell surface
The Hepatitis C Virus (HCV) facilitates CXCR2 ligand expression in response to the Epidermal Growth Factor (EGF) and is able to induce the EGF production by an autocrine circuit in its host cell
Hepatitis C virus inhibits IL-1β-induced IκBζ expression and thereby antagonizes mechanisms which may affect cell proliferation
Hepatitis
Comparative proteomic analysis reveals alterations of Sec61 ER-translocon at the acute and chronic stages of hepatitis C virus infection in a cell-based reporter system
Type I interferon elevates co-regulatory receptor expression on CMV- and EBV-specific CD8 T cells in Chronic Hepatitis C
An evolutionary approach of interspousal transmission of Hepatitis C Virus infection
Development of universal HCV vaccine by coupling HCV NS3 proteins to the surface of liposomes
Risk factors for sexual transmission of hepatitis C virus among men who have sex with men: a case-control study
Factors associated with undiagnosed hepatitis C infection among people who inject drugs and missed opportunities for testing in the United Kingdom
Development and evaluation of a HCV Ag-Ab COMB ELISA kit
Development of the de novo pyrosequencing assay system for HCV genotyping and mutation analysis
A simple, fast and cost-effective method to genotyping IL28B polymorphisms in chronic hepatitis C patients
Simple fibrosis tests APRI and platelet count accurately detect severe fibrosis or cirrhosis (METAVIR F3/F4) in chronic hepatitis C
Impact of interleukin 28B genotype on the virological responses in chronic hepatitis C treatment
Eligibility for actual antiviral treatment of chronically hcv infected patients addressed to a tertiary referral hepatology center
Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients
Development of treatment model for HIV/HCV co-infected OST patients as the basis for scaling up access to HCV treatment for key populations in Ukraine
Drug-drug interactions with novel all oral interferon free antiviral agents - all issues solved?
Telemedicine allows successful Hepatitis C treatment in Western Australian prisons
Novel peptides as entry inhibitors of Hepatitis C virus infection targeting two domains of envelope glycoprotein 2
Concordance between SVR4 and SVR24 in DAA Based Regimens: a real life experience including post-liver transplant patients
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis during IFN-free antiviral therapy
Early reduction of serum fibrosis marker and tumor marker in patients treated with daclatasvir and asunaprevir
A phenotypic NS3-protease inhibitor resistance assay to characterize resistance-associated mutations in patients
Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
Interim analysis for sofosbuvir national treatment program in Egypt
Effect of Sofosbuvir, Brand drug (Sofaldi) versus generic (Viropack) in treating chronic HCV infection among Egyptian patients
Improvement of virologic response and liver elasticity in HCV-patients after liver transplantation through treatment with the new direct-acting antivirals
Real-world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment
The hepatitis C virus contributes to the aggravation of the immunosuppressive environment by increasing the suppressive activity of natural regulatory T cells and inducing the emergence of type 1 regulatory T Cells
Elevated serum dipeptidyl peptidase 4 (DPP4) and interferon gamma inducible protein-10 (IP-10) levels demonstrated in obese patients with chronic hepatitis (CHC) potentially link obesity to unfavorable treatment response outcome
Epithelial-mesenchymal transition in hepatitis C virus and hepatitis C virus-related hepatocellular carcinoma in Egyptian patients
Associations of human leukocyte antigen class II DQB1 and susceptibility of hepatitis C virus (genotype 4): a family-based study in Egyptian population
Family based association study of interferon gamma (IFN-γ) +874 (T/A) gene polymorphism in Egyptian patients with hepatitis C virus genotype-4
Phenotype and functions of NK cells are significantly altered in HIV/HCV co-infection
Study of human liver fibrogenesis using human liver slices culture as a model
Experimental infection of bank voles with a novel Hepacivirus - a promising new animal model for Hepatitis C
Dose-related amelioration of peg-interferon based retinal vasculitis
A study of the prevalence and effects of insulin resistance in chronic hepatitis C patients with genotype 4
CD34 expression can predict a higher risk of development of Hepatocellular carcinoma in the setting of chronic Hepatitis C-related cirrhosis
A unique glycoprotein; Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP) is a disease-specific serum marker for liver fibrosis
The rate of hepatic decompensation of chronic Hepatitis C patients with advanced fibrosis after achieving sustained virological response
Modelling hepatitis C infection and pathogenicity with the human immune system and liver (HIL) mouse model
Are the immunomarkers in hepatocellular carcinoma correlated with prognosis pathological features?
Hepatitis B, delta and C viruses detection among HIV-infected individuals from Cape Verde
The cases of intrafamilial transmission of hepatitis delta virus in endemic region
Epidemiology and clinical course of hepatitis delta virus infection over 15 years in a liver center in Northern Italy
Hepatitis delta: a challenge in the Western Amazon, Rio Branco, Acre
Nucleic acid polymers are efficient in blocking hepatitis delta virus entry in vitro
Quantitative HBsAg level and its potential applications in patients with hepatitis D coinfection
Plasma cytokine and chemokine patterns during PEG-IFNa-2a therapy of chronic hepatitis delta
Molecular signatures reveal a novel HLA-B*15-restricted CD8 T cell epitope on the large hepatitis delta antigen
Generation of a cell line that supports the full lifecycle of Hepatitis Delta Virus
Development of a hepatitis delta virus screening method
Liver transplantation for hepatitis B with delta coinfection: a single center experience
Challenges in the management of chronic delta hepatitis in? Western Amazon, Rio Branco, Acre
Cellular immune responses in persistent hepatitis delta virus infection
Serology based retrospective study of viral hepatitis in A tertiary care hospital
Co- circulation of hepatitis A, B and C with hepatitis E virus genotype 1a during major outbreak of 2014 in Nepal
Hepatitis E IgG seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France
Epidemiology and risk factors of Hepatitis E virus infection in Tajikistan
Hepatitis E virus in the food chain in Germany
Hepatitis E virus in patients with HIV infection
Hepatitis E epidemic process in Russian Federation
Two generations of ‘Gold Standards:’ The impact of a decade in Hepatitis E Virus testing innovation on population seroprevalence
Phylogenetic analysis of hepatitis E virus sequences in Eastern India: genetic diversity, subtypes with varying degree of liver failure
Seroprevalence of hepatitis E virus (HEV) in Western Cape, South Africa
The HEV (genotype 2) intergenic-junction variant restores the CREX RNA ‘stem-loop’ integrity, essential for viral life cycle
Self inactivation of HEV protease
Hepatitis E virus circulation in humans, pigs and bats in Vietnam
Mutational analysis of hepatitis E virus ORF1 ‘X-domain’ identifies an evolutionary conserved macrodomain protein/Appr-1”-pase active-site, critical for viral RNA replication in hepatoma cells
Extrahepatic replication of hepatitis E virus in neuronal and placental cell lines
Towards the establishment of a rodent model of hepevirus infection using rat hepatitis E virus
Rabbit hepatitis E virus circulation in endemic and non-endemic regions
Hepatitis E Virus (HEV) in the countries of the Middle East and North Africa (MENA) Region: An awareness of an infectious threat to blood safety
Hepatitis E virus seroprevalence in the different population groups in Nizhny Novgorod, Russia
Detection and vertical transmission of hepatitis E virus (HEV) in Göttingen minipigs from a specified pathogen free facility
HEV infection at the national reference laboratory for viral hepatitis in Argentina: report of new cases diagnosed in 2014
Near full-length hepatitis E virus genome sequencing analysis in a chronically infected patient following ribavirin treatment failure
Antiviral therapy and viral fitness: temporal evolution of replication fitness HEV polymerase mutation during ribavirin therapy
Hepatitis E virus is unlikely to be the cause of neurological disease in genotype 1 endemic region
Chronic infection with Hepatitis E virus in pigs co-infected with the porcine reproductive and respiratory syndrome virus
Immune response and viral replication in experimentally hepatitis E virus-infected wild boar and domestic pigs
Hepatitis E virus super-infection and progression of liver disease in Vietnamese HBsAg-positive patients
Exacerbation of hepatitis E virus infection during anti-TNFα treatment
Broad geographical distribution of rat hepatitis E virus in wild Norway rats ( Rattus norvegicus ) from Europe
Phylogenetic characterization of HEV isolates from hepatitis E cases in Germany 2010-2014
Generation of hepatitis E virus-specific monoclonal antibodies
Hepatitis prevention, control, and elimination program in Mongolia: Innovation in combating viral hepatitis endemic
C-Myc plays a crucial role in chronic liver injury
A GATA-1 binding site mutation leads to reduced TRAIL expression in human HCC
The prognostic value and biological effects of glycoprotein QSOX1 on recurrence and metastasis of hepatocellular carcinoma
Human adult liver stem cells from patient samples
Curcumin protects against liver fibrosis in mice by attenuating infiltration of the Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1
Diagnostic accuracy of Acoustic Radiation Force Impulse Imaging (ARFI) for non-invasive liver fibrosis assessment in patients after orthotopic liver transplantation
Turquoise-III: safety and efficacy of 12-week ribavirin-free treatment for patients with HCV genotype 1b and cirrhosis